Publicaciones en colaboración con investigadores/as de Hospital Vall d'Hebron (377)

2024

  1. Consensus statement of the Spanish Society of Neurology on the treatment of multiple sclerosis and holistic patient management in 2023

    Neurologia, Vol. 39, Núm. 2, pp. 196-208

  2. Plasma fibrinogen and risk of vascular recurrence after ischaemic stroke: An individual participant and summary-level data meta-analysis of 11 prospective studies

    European Stroke Journal

  3. RhoA downregulation in the murine intestinal epithelium results in chronic Wnt activation and increased tumorigenesis

    iScience, Vol. 27, Núm. 4

  4. Surrogate endpoints in phase III randomized trials of advanced gastroesophageal cancer: A systematic review and meta-analysis

    Critical Reviews in Oncology/Hematology, Vol. 201

2023

  1. Assessment of dyspneic sensation in patients with type 2 diabetes

    Frontiers in Endocrinology, Vol. 14

  2. Borderline, Where Are You? A Psychometric Approach to the Personality Domains in the International Classification of Diseases, 11th Revision (ICD-11)

    Personality Disorders: Theory, Research, and Treatment, Vol. 14, Núm. 3, pp. 355-359

  3. Complex post-traumatic stress disorder (CPTSD) of ICD-11 in youths with childhood maltreatment: Associations with age of exposure and clinical outcomes

    Journal of Affective Disorders, Vol. 332, pp. 92-104

  4. Delivery Systems in Ocular Retinopathies: The Promising Future of Intravitreal Hydrogels as Sustained-Release Scaffolds

    Pharmaceutics, Vol. 15, Núm. 5

  5. Development of a Guide to Multidimensional Needs Assessment in the Palliative Care Initial Encounter (MAP)

    Journal of Pain and Symptom Management, Vol. 66, Núm. 4, pp. 361-369.e6

  6. Differentiating Abnormal, Normal, and Ideal Personality Profiles in Multidimensional Spaces

    Journal of Individual Differences, Vol. 44, Núm. 4, pp. 215-222

  7. Effectiveness of fosfomycin trometamol as oral step-down therapy for bacteraemic urinary tract infections due to MDR Escherichia coli: a post hoc analysis of the FOREST randomized trial

    The Journal of antimicrobial chemotherapy, Vol. 78, Núm. 7, pp. 1658-1666

  8. Evolution of quality indicators in acute stroke during the RACECAT Trial: Impact in the general population

    International Journal of Stroke, Vol. 18, Núm. 2, pp. 229-236

  9. Extracellular vesicles secreted by triple-negative breast cancer stem cells trigger premetastatic niche remodeling and metastatic growth in the lungs

    International Journal of Cancer, Vol. 152, Núm. 10, pp. 2153-2165

  10. First pass effect in posterior circulation occlusions: Analysis from the CICAT registry

    International Journal of Stroke, Vol. 18, Núm. 2, pp. 221-228

  11. Hopelessness in Patients with Early-Stage Relapsing-Remitting Multiple Sclerosis

    Patient Preference and Adherence, Vol. 17, pp. 1431-1439

  12. Improvements in quality of life over 2 years with cladribine tablets in people with relapsing multiple sclerosis: The CLARIFY-MS study

    Multiple Sclerosis Journal, Vol. 29, Núm. 14, pp. 1808-1818

  13. Influence of vascular imaging acquisition at local stroke centers on workflows in the drip-n-ship model: A RACECAT post hoc analysis

    Journal of NeuroInterventional Surgery, Vol. 16, Núm. 2, pp. 143-150

  14. Preventive isolation criteria for multidrug-resistant bacteria detection in patients admitted to the ICU: Multicenter study within the Zero Resistance program

    Medicina Intensiva, Vol. 47, Núm. 11, pp. 629-637

  15. Severity in the ICD-11 personality disorder model: Evaluation in a Spanish mixed sample

    Frontiers in Psychiatry, Vol. 13

  16. Sex and gender differences in acute stroke care: metrics, access to treatment and outcome. A territorial analysis of the Stroke Code System of Catalonia

    European Stroke Journal, Vol. 8, Núm. 2, pp. 557-565